Ypsomed Holding AG Logo

Ypsomed Holding AG

ISIN: CH0019396990 | Ticker: YPSN | LEI: 391200QLIOTTBNPNSI14
Sector: Health CareSub-Industry: Health Care Equipment
Country: Switzerland

About Ypsomed Holding AG

Company Description

The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 35 years experience. As a leader in innovation and technology, Ypsomed is the preferred partner for pharmaceutical and biotech companies for the supply of injections pens, autoinjectors and infusion systems to administer liquid drugs. Ypsomed promotes and sells its product portfolio under the umbrella brands, mylife Diabetescare directly to patients or through pharmacies and clinics, and under YDS Ypsomed Delivery Systems as business-to-business to pharmaceutical companies.

Ypsomed has its headquarters in Burgdorf, Switzerland, and operates a global network of manufacturing sites, subsidiaries and distributors.

Year founded


Served area





Brunnmattstrasse 6, 3401 Burgdorf – Switzerland

Filings & Publications

Sign up and we will give you access!

Insider Trades

Date Trading entity / Person Association Trade type Volume
29.09.23 None Executive member Sell CHF 40,800.00
23.06.22 None Non-Executive member Buy CHF 31,400.00
23.06.22 None Executive member Buy CHF 11,760.00
23.06.22 None Executive member Buy CHF 122.50
14.06.22 None Non-Executive member Buy CHF 1,080,875.72
13.06.22 None Non-Executive member Buy CHF 200,296.80
10.06.22 None Non-Executive member Buy CHF 203,240.19
07.06.22 None Non-Executive member Buy CHF 135,037.40
25.05.22 None Non-Executive member Buy CHF 68,736.00
24.03.22 None Non-Executive member Buy CHF 144,874.35

Capital markets information






Health Care

Industry Group

Health Care Equipment & Services


Health Care Equipment & Supplies


Health Care Equipment

Listed Stock Exchange

SIX Swiss Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.